Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Fructose Intolerance Is Common in Children with Abdominal Pain

By LabMedica International staff writers
Posted on 02 Nov 2010
Fructose malabsorption or fructose intolerance is common in children with recurrent or functional abdominal pain.

Fructose intolerance is typically diagnosed by exclusion that once other gastro-intestinal conditions like Crohn's disease and ulcerative colitis are ruled out, a hydrogen breath test is given to the patient. More...
If the patient's breath hydrogen exceeds 20 ppm points above baseline, then the patient is likely to be fructose intolerant.

Scientists at the Mary Bridge Children's Hospital, (Tacoma, WA, USA), investigated a total of 245 patients with unexplained chronic abdominal pain alone or associated with constipation, gas or bloating and/or diarrhea. The ages ranged from 2 to 18 years old, with a median age of 11 and 62.1% were female. The patients received a standard dose of fructose (1 g/kg, to a maximum of 25 g), followed by a breath hydrogen test (BHT), which measured methane levels at 30-minute intervals for 90 minutes. The test for fructose was performed in all patients in the study and it was positive for fructose intolerance in 132 of 245 patients (53.9 %). A total of 113 of 245 (46.1%) of patients had a negative BHT for fructose intolerance. All of the 132 patients with a positive BHT for fructose had a nutritional consult with a registered dietician and were placed on a low-fructose diet. Using a standard pain scale for children, 88 of the 132 patients (67.7%) reported resolution of symptoms on a low-fructose diet.

Daniel Lustig, M.D., a pediatric gastroenterologist at the hospital, said, "Fructose intolerance is more prevalent in teenage girls with chronic abdominal pain. While there is definitely a subset of patients who respond well to a low-fructose diet, it is challenging for patients who are fructose intolerant to maintain, especially teenagers. But the good news is that over half of patients who are fructose intolerant are able to maintain a low-fructose diet and are able to notice an immediate improvement in their symptoms.” The results of the study were unveiled at the American College of Gastroenterology's 75th Annual Scientific meeting, October 15 - 20, 2010, in San Antonio, TX, USA.

Related Links:
Mary Bridge Children's Hospital




Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.